| MDR | multidrug resistance |
| ABCB1 | ATP Binding Cassette Subfamily B Member 1 |
| P-gp | P glycoprotein |
| MAPK | mitogen activated protein kinase |
| NF κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| ICTRP | Clinical Trials Registry Platform |
| ToxRTool | toxicological data reliability assessment tool |
| SYRCLE | Systematic Review Centre for Laboratory animal Experimentation |
| RoB | Risk Of Bias |
| CAF | cancer-associated fibroblast |
| PTX | paclitaxel |
| SBSGL | Sporoderm-Broken Spores of Ganoderma lucidum |
| GAD | Ganoderic Acid D |
| MPSSS | polysaccharide extracted from Lentinula edodes |
| CAFs-CM | conditioned medium derived from cancer-associated fibroblasts |
| CAFs-TCM | conditioned medium derived from cancer-associated fibroblasts pre-treated with polysaccharide extracted from Lentinula edodes |
| IC50 | Half maximum inhibitory concentration |
| TGF-β1 | Transforming growth factor beta 1 |
| miR | microRNA |
| ERK | Extracellular signal-regulated kinases |
| ROS | reactive oxygen species |
| IL | interleukin |
| HLA | human leukocyte antigen |
| PSA | prostate-specific antigen |